|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 恶性肿瘤的止血显示文摘恶性肿瘤使止血系统发生显著改变。50%癌症病人和约95%转移性肿瘤病人可检测到止血系统的一些实验室指标异常,其中9~15%发展为弥漫性血管内凝血(DIC),引起致命后果——血栓或出血。据报告,1~11%恶性肿瘤病人发生血栓栓塞,尸检报导更高。约10%癌症病人发生出血,其中1/2由化疗所致血小板减少引起,1/3是因肿瘤直接侵袭,仅约10%系DIC所致。总之,血栓栓塞和出血是癌症病人死亡的第二大原因。癌症与止血系统的相互作用是复杂的,本文将讨论(1)其相互作用的病理生理学;(2)这些变化引起的临床综合征;(3)该临床综合征的处理。 | Nand S Messmore H 钱文斌 | 1991 | 国外医学(输血及血液学分册)1991，14，4： | 4 |
| 2 | Hemostasis in malignancy 显示文摘 | Nand S Messmore H | 1990 | Am J Hematol1990，35，1： | 1 |
| 3 | Clinical differentiation of low molecular weight heparins显示文摘 | Mammen E Arcelus J Messmore H | 1999 | Semin Thromb Hemost1999，25，3： | 1 |
| 4 | Simple scoring system for early management of heparin-induced thrombocytopenia显示文摘 | Messmore HL Fabbrini N Bird ML | 2011 | Clin Appl Thromb Hemost2011，17，2： | 1 |
| 5 | Interaction of heparinoids with platelets: comparison with heparin and low molecular weight heparins显示文摘 | Messmore HL Griffin B Koza M | 1991 | Semin Thromb Hemost1991，17，1： | 1 |
| 6 | Interaction of heparinoids with platelets: comparison with heparin and low molccular weight heparins显示文摘 | Messmore IlL Griffin B Koza M | 1991 | Semin Thromb Hemost1991，17，1： | 1 |
| 7 | Ciradianinterrelation ships among levels of plasma fibrinogen,bloodplatelets,and serum interleukin-6显示文摘 | Kanabrocki EL Sothem RB Messmore HL | 1999 | Clin Appl ThrombHemost1999，5，1： | 1 |
| 8 | Mcchanisms of Ve- nous and Arterial Thrombosis in Heparin- induced Throm boeytopenia显示文摘 | Walenga JM Jeske WP Messmore HI | 2000 | Journal of Thrombosis and Thrombolysis2000，10，1： | 1 |
| 9 | Pulmonary arterial hypertension 显示文摘 | Puglisi Jos Luis Wehrmacher William H Messmore Harry | 2007 | Comprehensive therapy2007，33，4： | 1 |
| 10 | Circadian interrela- tionships among levels of plasma fibrinogen, blood platelets, and serum interleukin-6 显示文摘 | Kanabrocki EL Sothern RB Messmore IlL et aL | 1999 | Clin Appl Thromb Hemost1999，5，1： | 1 |
| 11 | Anti-thrombotic agents in the treatment of severe sepsis显示文摘 | Iqbal O Messmore H Fareed J | 2002 | Expert Opin Emerg Drugs2002，7，1： | 1 |
| 12 | Hemostasis in malignancy 显示文摘 | Nand S Messmore H | 1990 | Am J Hematol1990，35，1： | 1 |
| 13 | Hemostasis in malignancy显示文摘 | Nands Messmore H | 1990 | Am J Haemato1990，35，1： | 1 |
| 14 | Fareed J, Differential effects of DX-9065a, argatroban, and synthetic pentasaccharide on tissue thromboplastin in hibition test and dilute Russell's viper venom test显示文摘 | GerbutaviciusR lqbalo Messmore HL | 2003 | Clin Appl Thromb Hemost2003，9，： | 1 |
| 15 | Hemostasis in malignancy 显示文摘 | Nand S Messmore H | 1990 | Am J Hematol1990，35，1： | 1 |
| 16 | Potential use of recombinant hirudin as an anticoagulant in a car diopulmation bypass model显示文摘 | Walenga JM Bakhos M Messmore HL | 1991 | Ann Thorac Surg1991，51，： | 1 |
| 17 | Hemostasis in malignancy显示文摘 | Nancl S Messmore H | 1990 | Am J Hematol1990，35，： | 1 |
| 18 | Hemostasis in malignancy显示文摘 | | 1990 | Am J Haemato1990，35，1： | 1 |
| 19 | Hemostasis in malignancy 显示文摘 | Nand S Messmore H | 1990 | Am J Hematol1990，35，1： | 1 |
| 20 | Antithrombotic agents in the treatment of severe sepsis显示文摘 | Iqbal O Messmore H Fareed J | 2002 | Expert Opin Emerg Drugs2002，7，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员